1/5/22 17:22 | 1/3/22 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Herrmann John A III | MD | O | EVP,GC | S.d | -705 | 140.91 | 0 | -5 | -47 | 6 | D | | | | | | | | | | | | | | |
12/22/21 17:03 | 12/20/21 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Herrmann John A III | MD | O | EVP,GC | S.d | -1,150 | 230.00 | 0 | -5 | -47 | 6 | D | | | | | | | | | | | | | | |
12/3/21 18:30 | 12/1/21 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Herrmann John A III | MD | O | EVP,GC | S.d | -981 | 196.19 | 0 | -5 | -53 | 5 | D | | | | | | | | | | | | | | |
12/1/21 17:02 | 11/29/21 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Herrmann John A III | MD | O | EVP,GC | S.d | -1,144 | 228.72 | 0 | -5 | -53 | 5 | D | | | | | | | | | | | | | | |
11/5/21 17:02 | 11/3/21 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Herrmann John A III | MD | O | EVP,GC | S.d | -1,000 | 200.00 | 0 | -5 | -53 | 5 | D | | | | | | | | | | | | | | |
11/3/21 16:49 | 11/1/21 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Herrmann John A III | MD | O | EVP,GC | S.d | -815 | 163.08 | 0 | -5 | -53 | 5 | D | | | | | | | | | | | | | | |
10/5/21 17:02 | 10/1/21 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Herrmann John A III | MD | O | EVP,GC | S.d | -874 | 174.89 | 0 | -5 | -53 | 5 | D | | | | | | | | | | | | | | |
9/17/21 17:11 | 9/15/21 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Herrmann John A III | MD | O | EVP,GC | S.d | -1,147 | 229.44 | 0 | -5 | -88 | 1 | D | | | | | | | | | | | | | | |
9/3/21 17:10 | 9/1/21 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Herrmann John A III | MD | O | EVP,GC | S.d | -1,240 | 247.97 | 0 | -5 | -88 | 1 | D | | | | | | | | | | | | | | |
7/28/21 17:00 | 7/26/21 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Herrmann John A III | MD | O | EVP,GC | S.d | -573 | 197.74 | 0 | -3 | -80 | 1 | D | | | | | | | | | | | | | | |
7/2/21 17:01 | 6/30/21 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Herrmann John A III | MD | O | EVP,GC | S.d | -616 | 212.66 | 0 | -3 | -80 | 1 | D | | | | | | | | | | | | | | |
6/2/21 16:59 | 5/28/21 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Herrmann John A III | MD | O | EVP,GC | S.d | -432 | 149.14 | 0 | -3 | -91 | 0 | D | | | | | | | | | | | | | | |
5/4/21 18:03 | 4/30/21 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Herrmann John A III | MD | O | EVP,GC | S.d | -694 | 239.83 | 0 | -3 | -91 | 0 | D | | | | | | | | | | | | | | |
3/30/21 18:10 | 3/26/21 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Herrmann John A III | MD | O | EVP,GC | S.d | -541 | 186.80 | 0 | -3 | -91 | 0 | D | | | | | | | | | | | | | | |
3/2/21 17:37 | 2/26/21 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Herrmann John A III | MD | O | EVP,GC | S.d | -653 | 225.48 | 0 | -3 | -91 | 0 | D | | | | | | | | | | | | | | |
2/3/21 17:37 | 2/1/21 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Herrmann John A III | MD | O | EVP,GC | S.d | -3,628 | 241.50 | 0 | -15 | -98 | 0 | D | | | | | | | | | | | | | | |
9/30/20 21:30 | 9/28/20 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Herrmann John A III | MD | O | EVP,GC | S.dm | -4,665 | 109.04 | 0 | -43 | -99 | 0 | D | | | | | | | | | | | | | | |
8/20/20 18:20 | 8/18/20 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Herrmann John A III | MD | O | EVP,GC | S.d | -6,674 | 144.33 | 0 | -46 | -99 | 0 | D | | | | | | | | | | | | | | |
5/20/20 16:35 | 5/18/20 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Herrmann John A III | MD | O | SVP,GC | S.d | -641 | 49.44 | 0 | -13 | -98 | 0 | D | | | | | | | | | | | | | | |
9/18/19 16:14 | 9/17/19 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Herrmann John A III | MD | O | SVP,GC | S | -26 | 7.07 | 0 | -4 | -100 | 0 | D | | | | | | | | | | | | | | |
12/18/15 17:10 | 12/16/15 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Herrmann John A III | MD | O | SVP,GC | S | -241 | 8.64 | 33 | -28 | -100 | 0 | D | 94 | 47 | -8 | -18 | 11 | 11 | 5 | 17 | 1 | -1 | -27 | -38 | -20 | -82 |